[Effect of regulation of Y-box protein 1 by RNA interference on the doxorubicin induced mdr1 gene expression in K562 cells]
Related Experiment Video
Updated: May 30, 2026

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Hui-Ling Shen1, Wen-Lin Xu, Qiao-Yun Chen
1Department of Central Laboratory, the Affiliated People's Hospital of Jiangsu University, Zhenjiang 212002, China.
Objective:
To investigate the effect of YB-1 on the transcription of induced mdr1 gene expression in K562 cells.
Methods:
K562 cells were treated with doxorubicin (DOX) at different concentrations and times. Expression of mdr1 and YB-1 genes was examined by RT-PCR and P-glycoprotein (P-gp) by flow cytometry. Cyto/nuclear protein was extracted for YB-1 detection by Western blotting. The expression of YB-1 gene in K562 cells was inhibited by YB-1 gene specific RNA interference (RNAi), then the expression of mdr1 and P-gp in YB-1 gene silenced cells treated with DOX was detected.
Results:
The mdr1 gene as well as its corresponding protein P-gp was highly expressed in DOX exposed K562 cells. DOX up-regulated the expression of YB-1 gene, and promoted YB-1 protein nuclear translocation. On YB-1 gene silenced, the expressions of mdr1 gene and P-gp were obviously down-regulated in DOX treated K562 cells.
Conclusion:
Doxorubicin can induce the expression of mdr1 gene in K562 cells, which may result from the transcription of mdr1 gene by activated YB-1.
Insights
Doxorubicin (DOX) induces multidrug resistance 1 (mdr1) gene expression in K562 cells. This is mediated by the Y-box binding protein 1 (YB-1), which translocates to the nucleus and activates mdr1 transcription.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
- The mdr1 gene encodes P-glycoprotein (P-gp), a key efflux pump in MDR.
- YB-1 is a transcription factor implicated in cellular stress responses and gene regulation.
Purpose of the Study:
- To elucidate the role of YB-1 in doxorubicin-induced mdr1 gene expression in K562 cells.
Main Methods:
- K562 cells were treated with doxorubicin (DOX).
- Gene and protein expression (mdr1, YB-1, P-gp) were analyzed using RT-PCR, flow cytometry, and Western blotting.
- YB-1 expression was inhibited using RNA interference (RNAi).
Main Results:
- DOX treatment increased mdr1 and P-gp expression in K562 cells.
- DOX also upregulated YB-1 expression and promoted its nuclear translocation.
- Silencing YB-1 significantly reduced mdr1 and P-gp expression in DOX-treated cells.
Conclusions:
- Doxorubicin induces mdr1 gene expression in K562 cells.
- Activated YB-1 appears to be a key mediator in the transcriptional regulation of mdr1 by doxorubicin.
Related Concept Videos
Regulation of Expression at Multiple Steps
Abnormal Proliferation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Negative Regulator Molecules
Master Transcription Regulators
